Oct 14, 2026 · 31 min
AI doubts and inflation pressure stocks as defensives emerge
Nasdaq, Small Caps Hit On AI Worries, Pesky Inflation: Dell, GILD, THC In Focus
The episode maps a fragile market backdrop while identifying whether healthcare leaders can offer actionable strength amid technology-sector weakness.
- 1Inflation, rising Treasury yields, weak breadth, and distribution pressure pushed major indexes toward key moving averages.
- 2AI infrastructure selling spread from smaller operators into Dell and other enterprise hardware stocks, raising broader leadership concerns.
- 3Healthcare showed relative strength as Gilead broke out and Tenet Healthcare built a potential early-entry setup.
Don't miss
Gilead Sciences breaks through a buy point as healthcare strength contrasts with the breakdown in AI-linked technology stocks.
The brief
Alissa Coram and Ken Shreve open with a sharp stock-market decline, linking pressure on the Nasdaq and small caps to inflation, Treasury yields, and doubts about AI infrastructure spending.
The technical picture is deteriorating: breadth is weak, distribution days are accumulating, and small caps remain below their 200-day moving average as defensive capital moves toward healthcare and staples.
AI infrastructure selling intensifies across neocloud and data-center names, while Dell, Hewlett Packard Enterprise, and NetApp show how weakness in enterprise hardware can spread beyond a single stock.
The hosts frame Taiwan Semiconductor’s test of its 50-day line as a key semiconductor signal, with upcoming earnings potentially deciding whether the group bounces or deteriorates further.
Gilead Sciences breaks through a buy point, while Tenet Healthcare develops the right side of a base near its 50-day line, giving the defensive rotation two distinct setups.
The standout contrast is between technology leadership breaking down and healthcare strengthening, a shift that could determine whether the market’s broader uptrend survives.
What was said on this episode
15 statements · 10 positive · 5 negative
The Nasdaq experienced an unequivocal distribution day
“this was unequivocal distribution”
Listen at 8:03
Trimming market exposure makes sense after the decline
“trimming exposure. Makes sense”
Listen at 8:41
TSMC's growth story remains intact
“the growth story is still very much intact for TSMC”
Listen at 10:48
XLV is an actionable ETF for healthcare strength
“this is, you know, this is an actionable ETF here”
Listen at 16:25
Traders should avoid chasing the consumer staples ETF after its rise
“I don't know that I would be chasing this one”
Listen at 17:38
XLV appears preferable for playing healthcare strength
“XLV probably looks like the better play here”
Listen at 18:15
A violent Dell break below $500 would signal selling
“if it violently breaks below that 500 level it would be a sell signal”
Listen at 20:01
Dell breaking its 10-week moving average is a classic sell signal
“a break on the weekly chart, a break of that 10-week moving average is just a classic sell signal”
Listen at 20:31
Leading stocks breaking down can signal a longer-term market pullback
“when the real true leaders start to break down, this can often be a sign of a kind of a longer-term market pullback”
Listen at 22:23
Gilead is currently actionable for investors
“I think it's a stock that is actionable right here”
Listen at 23:13
Gilead operates across oncology and immunology in addition to HIV and hepatitis C
“they're also in oncology, some forms of cancer, and also immunology”
Listen at 24:07
Gilead is expected to return to profitability in 2027
“going to ramp back up to profitability in 2027”
Listen at 24:37
Healthcare and biotech could perform well in 2027
“2027 could be a nice year for healthcare and biotech”
Listen at 25:03
Gilead may outperform in 2027
“we'll see if Gilead can be a nice outperformer in 2027”
Listen at 25:26
Tenant Healthcare's hospital-operator group is top-ranked
“THC and the hospital group, that's another top-ranked group in the market”
Listen at 29:04
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.